Kelly S Klega

9PUBLICATIONS
87CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 26, 2026
A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study.

|Nov 03, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.

Riaz Gillani, David S Shulman, Natalie J DelRocco

|Feb 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.

Riaz Gillani, David S Shulman, Natalie J DelRocco

|Dec 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.

Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey

|Feb 13, 2023
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.

Peter Anderson, Maurizio Ghisoli, Brian D Crompton

Pageof 2

Frequent Collaborators

8 joint publications

Brian D Crompton

4 joint publications

Steven G DuBois

4 joint publications

Mohammad Tanhaemami

3 joint publications

David S Shulman